Alva-Amco Pharmacal has been sold to Kobayashi Pharmaceutical
Based in Niles, Illinois, Alva-Amco Pharmacal is a leading provider of branded over-the-counter (OTC) consumer health products across a number of product categories, including skin care, women’s health, antifungals, upset stomach and pain treatments. For decades, Alva-Amco has provided safe and effective OTC treatments that allow consumers to live well and take charge of their health. The company sells its portfolio of specialty brands across all major pharmacies, grocery stores, mass retailers and online channels in the United States and Canada. For more information, please visit www.alva-amco.com.
Lincoln acted as an advisor to Alva-Amco, working closely with the Alva-Amco management team and shareholders throughout the sale process. Terms of the transaction were not disclosed.
Lincoln was a valued partner throughout the transaction, exceeding expectations and enabling management to remain focused on running the business. We are excited that Lincoln helped us find the right partner at this exciting time in our industry, and we are thrilled to join with Kobayashi as we embark on the next phase of our growth.
Meet our Senior Team
View More Transactions
Lincoln International is pleased to announce that it has provided mergers and acquisitions (M&A) and debt advice to MML Capital on its investment into Western Global
Lincoln International is pleased to announce that Homedical Atenção Domiciliar received a strategic investment from Crescera Capital, a leading Brazilian private equity fund
Lincoln International is pleased to announce that it has advised Trèves Group on all aspects of its acquisition of CTA Acoustics, a portfolio company of Cerberus Capital Management
Lincoln International is pleased to announce that Feel Good Organics, LLC (FGO), has been sold to HPH II Investments Master Fund, LP together with its related entities, a private equity fund managed by WM Partners